Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Dilantin Infatabs (Phenytoin).
Allergy: Some people who are allergic to Carbamazepine or barbiturates also experience allergic reactions to Dilantin Infatabs (Phenytoin). Before you take Dilantin Infatabs (Phenytoin), inform your doctor about any previous adverse reactions you have had to medications, especially other medications for seizures. Contact your doctor at once if you experience signs of an allergic reaction, such as skin rash, itching, difficulty breathing, or swelling of the face and throat.
Blood counts: Dilantin Infatabs (Phenytoin) can decrease the number of neutrophils (a type of white blood cell that helps fight infection), red blood cells (which carry oxygen), and platelets (which help your blood to clot). Your doctor will do blood tests to monitor this. If you notice any signs of infection (e.g., fever, chills, or sore throat) or unusual bleeding or bruising, contact your doctor immediately.
Dental hygiene: Because Dilantin Infatabs (Phenytoin) can cause swollen and bleeding gums, it is important to practice good dental hygiene by flossing, brushing, and visiting your dentist regularly. Talk to your doctor to learn more about how to take care of your mouth, gums, and teeth while taking Dilantin Infatabs (Phenytoin).
Diabetes: Dilantin Infatabs (Phenytoin) can decrease the release of insulin from the pancreas, resulting in higher-than-normal levels of glucose (sugar) in the blood. It may also have an effect on the action of medications used to lower blood sugar for people with diabetes.
If you have diabetes, or are at risk of developing diabetes, discuss with your doctor how Dilantin Infatabs (Phenytoin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Dilantin Infatabs (Phenytoin), and whether any special monitoring is needed. It may be necessary to monitor your blood sugar more closely when starting or stopping Dilantin Infatabs (Phenytoin) treatment.
If you experience symptoms of increased blood sugar, such as increased urinary frequency, increased thirst, excessive eating, unexplained weight loss, or a fruity breath odour, contact your doctor.
Drowsiness/reduced alertness: Some people who take Dilantin Infatabs (Phenytoin) become drowsy. Avoid activities that require complete mental alertness, judgment, and physical coordination (such as driving a car or performing hazardous tasks) until you establish how you are affected by Dilantin Infatabs (Phenytoin).
Hypersensitivity syndrome: A Anaphylaxis (severe allergic reaction) called hypersensitivity syndrome has occurred for some people with the use of Dilantin Infatabs (Phenytoin). Stop taking the medication and get immediate medical attention if you have symptoms of a severe allergic reaction, including fever, swollen glands, yellowing of the skin or eyes, or flu-like symptoms with skin rash or blistering. These reactions may be more frequent in people of Asian origin, those with immune system problems or those who have a history of similar reactions to other seizure medications.
Lactose intolerance: This capsule form of Dilantin Infatabs (Phenytoin) contains lactose. If you have galactose intolerance (galactosemia, glucose-galactose malabsorption, or Lapp lactase deficiency), you should not take the capsule form of Dilantin Infatabs (Phenytoin).
Liver function: Some people have reported liver problems and, in rare instances, liver failure, with the use of Dilantin Infatabs (Phenytoin). These cases have been associated with an allergic reaction that includes fever, skin rashes or Hives, or swollen lymph glands. The reaction usually occurs within the first 2 months of treatment.
If you experience symptoms of liver problems such as fatigue, feeling unwell, loss of appetite, nausea, yellowing of the skin or whites of the eyes, dark urine, pale stools, abdominal pain or swelling, and itchy skin, contact your doctor immediately. If you have decreased liver function or liver disease, discuss with your doctor how Dilantin Infatabs (Phenytoin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Dilantin Infatabs (Phenytoin), and whether any special monitoring is needed.
Osteoporosis: Long term use of anti-seizure medications, including Dilantin Infatabs (Phenytoin), may affect the strength of your bones, because these medications reduce the amount of vitamin D available for your body to use. If you have or are at risk for developing osteoporosis, discuss with your doctor whether you need to take additional vitamin D.
Other medications and alcohol: Many medications and alcoholic beverages interact with Dilantin Infatabs (Phenytoin), causing decreased effectiveness or increased side effects. If you are taking Dilantin Infatabs (Phenytoin), consult with your doctor or pharmacist before taking any other medications or drinking alcoholic beverages.
Regular dosing: Remember that when you are taking Dilantin Infatabs (Phenytoin), it is very important to take the medication exactly as prescribed. Inform your doctor of any condition that prevents you from taking the medication as prescribed (e.g., surgery, illness, difficulty swallowing).
Stopping the medication: Do not stop taking Dilantin Infatabs (Phenytoin) without consulting your doctor. Stopping the medication suddenly may cause an increase in the number or severity of seizures. If it is necessary to stop taking Dilantin Infatabs (Phenytoin), talk to your doctor about how to gradually reduce the dose of the medication before completely stopping.
Suicidal thoughts and behaviour: Some people taking anti-seizure medications may have suicidal thoughts or behaviour. If this happens to you or you notice this in a family member who is taking Dilantin Infatabs (Phenytoin), contact your doctor immediately. You should be closely monitored by your doctor for emotional and behaviour changes while taking Dilantin Infatabs (Phenytoin).
Pregnancy: When Dilantin Infatabs (Phenytoin) is taken during pregnancy, it may cause harm to the developing baby. Dilantin Infatabs (Phenytoin) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Dilantin Infatabs (Phenytoin), contact your doctor immediately.
Breast-feeding: Dilantin Infatabs (Phenytoin) passes into breast milk. If you are a breast-feeding mother and are taking Dilantin Infatabs (Phenytoin), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Seniors: People over the age of 65 are more likely to experience side effects of taking Dilantin Infatabs (Phenytoin). Doses for seniors should generally be lower and increase more slowly than for other adults.
